Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.

Ermisch M, Bucsics A, Vella Bonanno P, Arickx F, Bybau A, Bochenek T, van de Casteele M, Diogene E, Fürst J, Garuolienė K, van der Graaff M, Gulbinovič J, Haycox A, Jones J, Joppi R, Laius O, Langner I, Martin AP, Markovic-Pekovic V, McCullagh L, Magnusson E, Nilsen E, Selke G, Sermet C, Simoens S, Sauermann R, Schuurman A, Ramos R, Vlahovic-Palcevski V, Zara C, Godman B.

Front Pharmacol. 2016 Sep 28;7:305.

2.

Trend of Biosimilars Prescribing In A Croatian Teaching Hospital.

Stanic Benic M, Jakovac S, Zekic T, Vlahovic-Palcevski V.

Clin Ther. 2016 Oct 6;38(10S):e28. doi: 10.1016/j.clinthera.2016.07.155. No abstract available.

PMID:
27673651
3.

How can we improve antibiotic prescribing in primary care?

Dyar OJ, Beović B, Vlahović-Palčevski V, Verheij T, Pulcini C;  on behalf of ESGAP (the ESCMID [European Society of Clinical Microbiology and Infectious Diseases] Study Group for Antibiotic Policies)..

Expert Rev Anti Infect Ther. 2016;14(4):403-13. doi: 10.1586/14787210.2016.1151353. Review.

PMID:
26853235
4.

Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future.

Marković-Peković V, Škrbić R, Petrović A, Vlahović-Palčevski V, Mrak J, Bennie M, Fadare J, Kwon HY, Schiffers K, Truter I, Godman B.

Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):609-618. Epub 2015 Dec 15.

PMID:
26671843
5.

Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options.

Milic S, Mikolasevic I, Krznaric-Zrnic I, Stanic M, Poropat G, Stimac D, Vlahovic-Palcevski V, Orlic L.

Drug Des Devel Ther. 2015 Aug 20;9:4835-45. doi: 10.2147/DDDT.S64877. Review.

6.

European survey on principles of prudent antibiotic prescribing teaching in undergraduate students.

Pulcini C, Wencker F, Frimodt-Møller N, Kern WV, Nathwani D, Rodríguez-Baño J, Simonsen GS, Vlahović-Palčevski V, Gyssens IC; ESGAP Curriculum Working Group..

Clin Microbiol Infect. 2015 Apr;21(4):354-61. doi: 10.1016/j.cmi.2014.11.015.

7.

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Godman B, Malmström RE, Diogene E, Gray A, Jayathissa S, Timoney A, Acurcio F, Alkan A, Brzezinska A, Bucsics A, Campbell SM, Czeczot J, de Bruyn W, Eriksson I, Yusof FA, Finlayson AE, Fürst J, Garuoliene K, Guerra Júnior A, Gulbinovič J, Jan S, Joppi R, Kalaba M, Magnisson E, McCullagh L, Miikkulainen K, Ofierska-Sujkowska G, Pedersen HB, Selke G, Sermet C, Spillane S, Supian A, Truter I, Vlahović-Palčevski V, Vien LE, Vural EH, Wale J, Władysiuk M, Zeng W, Gustafsson LL.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):77-94. doi: 10.1586/17512433.2015.990380. Review.

PMID:
25487078
8.

Quality indicators as a tool in improving the introduction of new medicines.

Campbell SM, Godman B, Diogene E, Fürst J, Gustafsson LL, MacBride-Stewart S, Malmström RE, Pedersen H, Selke G, Vlahović-Palčevski V, van Woerkom M, Wong-Rieger D, Wettermark B.

Basic Clin Pharmacol Toxicol. 2015 Feb;116(2):146-57. doi: 10.1111/bcpt.12295.

9.

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.

Godman B, Wettermark B, van Woerkom M, Fraeyman J, Alvarez-Madrazo S, Berg C, Bishop I, Bucsics A, Campbell S, Finlayson AE, Fürst J, Garuoliene K, Herholz H, Kalaba M, Laius O, Piessnegger J, Sermet C, Schwabe U, Vlahović-Palčevski VV, Markovic-Pekovic V, Vončina L, Malinowska K, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 17;5:106. doi: 10.3389/fphar.2014.00106. Review.

10.

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.

Godman B, Malmström RE, Diogene E, Jayathissa S, McTaggart S, Cars T, Alvarez-Madrazo S, Baumgärtel C, Brzezinska A, Bucsics A, Campbell S, Eriksson I, Finlayson A, Fürst J, Garuoliene K, Gutiérrez-Ibarluzea I, Hviding K, Herholz H, Joppi R, Kalaba M, Laius O, Malinowska K, Pedersen HB, Markovic-Pekovic V, Piessnegger J, Selke G, Sermet C, Spillane S, Tomek D, Vončina L, Vlahović-Palčevski V, Wale J, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 10;5:109. doi: 10.3389/fphar.2014.00109. Review.

11.

Potentially inappropriate prescribing in elderly outpatients in Croatia.

Popović B, Quadranti NR, Matanović SM, Lisica ID, Ljubotina A, Duliba DP, Vlahović-Palčevski V.

Eur J Clin Pharmacol. 2014 Jun;70(6):737-44. doi: 10.1007/s00228-014-1667-0.

PMID:
24647976
12.

Potentially inappropriate prescribing to the elderly: comparison of new protocol to Beers criteria with relation to hospitalizations for ADRs.

Matanović SM, Vlahović-Palčevski V.

Eur J Clin Pharmacol. 2014 Apr;70(4):483-90. doi: 10.1007/s00228-014-1648-3.

PMID:
24458542
13.

Personalizing health care: feasibility and future implications.

Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Herholz H, Hviding K, Jan S, Kalaba M, Kvalheim C, Laius O, Lööv SA, Malinowska K, Martin A, McCullagh L, Nilsson F, Paterson K, Schwabe U, Selke G, Sermet C, Simoens S, Tomek D, Vlahovic-Palcevski V, Voncina L, Wladysiuk M, van Woerkom M, Wong-Rieger D, Zara C, Ali R, Gustafsson LL.

BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179. Review.

14.

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Jones J, Joppi R, Kalaba M, Kvalheim C, Laius O, Langner I, Lonsdale J, Lööv SÄ, Malinowska K, McCullagh L, Paterson K, Markovic-Pekovic V, Martin A, Piessnegger J, Selke G, Sermet C, Simoens S, Tulunay C, Tomek D, Vončina L, Vlahovic-Palcevski V, Wale J, Wilcock M, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2013 May 14;4:39. doi: 10.3389/fphar.2013.00039.

15.

Mycophenolate mofetil induced severe, life threatening lower gastrointestinal bleeding - case report.

Hauser G, Bubic I, Vlahovic-Palcevski V, Spanjol J, Stimac D.

Nefrologia. 2013 Jan 18;33(1):146-7. doi: 10.3265/Nefrologia.pre2012.Jun.11512. No abstract available.

16.

Potentially inappropriate medications in the elderly: a comprehensive protocol.

Mimica Matanović S, Vlahovic-Palcevski V.

Eur J Clin Pharmacol. 2012 Aug;68(8):1123-38. doi: 10.1007/s00228-012-1238-1. Review.

PMID:
22362342
17.

Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.

Palčevski G, Skočibušić N, Vlahović-Palčevski V.

Eur J Clin Pharmacol. 2012 Jul;68(7):1073-7. doi: 10.1007/s00228-012-1221-x.

PMID:
22307225
18.

Postmarketing surveillance.

Vlahović-Palčevski V, Mentzer D.

Handb Exp Pharmacol. 2011;205:339-51. doi: 10.1007/978-3-642-20195-0_17.

PMID:
21882120
19.

Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future.

Vončina L, Strizrep T, Godman B, Bennie M, Bishop I, Campbell S, Vlahović-Palčevski V, Gustafsson LL.

Expert Rev Pharmacoecon Outcomes Res. 2011 Aug;11(4):469-79. doi: 10.1586/erp.11.42.

PMID:
21831028
20.

Health Alliance for prudent antibiotic prescribing in patients with respiratory tract infections (HAPPY AUDIT) -impact of a non-randomised multifaceted intervention programme.

Bjerrum L, Munck A, Gahrn-Hansen B, Hansen MP, Jarbol DE, Cordoba G, Llor C, Cots JM, Hernández S, López-Valcárcel BG, Pérez A, Caballero L, von der Heyde W, Radzeviciene R, Jurgutis A, Reutskiy A, Egorova E, Strandberg EL, Ovhed I, Mölstad S, Stichele RV, Benko R, Vlahovic-Palcevski V, Lionis C, Rønning M.

BMC Fam Pract. 2011 Jun 20;12:52. doi: 10.1186/1471-2296-12-52.

Supplemental Content

Loading ...
Support Center